
An analysis of Amicus Therapeutics Inc. (FOLD) stock, currently priced at $9.51, highlights potential options strategies for institutional investors. Selling an $8.00 strike put for a $0.10 premium offers a 1.25% return if the contract expires worthless, with a 75% probability. Alternatively, a covered call strategy utilizing a $12.00 strike call for $0.10 could yield a 27.23% total return if the stock is called away by December 2026. The report also notes significant implied volatilities of 95% for puts and 86% for calls, contrasting with the 42% trailing actual volatility, providing context for risk assessment.
The article details two specific options strategies for Amicus Therapeutics Inc. (FOLD), currently trading at $9.51, designed to enhance returns or manage entry points. Selling an $8.00 strike put contract, with a current bid of $0.10, offers an effective entry price of $7.90, representing a 16% discount to the current market price. This strategy yields a 1.25% return (1.12% annualized) if the contract expires worthless, which has a 75% probability. Alternatively, a covered call strategy utilizing a $12.00 strike call expiring in December 2026, also with a $0.10 bid, could generate a total return of 27.23% if the stock is called away. This strike price represents a 26% premium to the current trading price. If the call expires worthless, which has a 42% probability, the investor still collects a 1.05% premium (0.94% annualized). A notable observation is the significant divergence between implied and historical volatility. The implied volatility for the put contract is 95% and 86% for the call contract, substantially higher than FOLD's trailing twelve-month actual volatility of 42%. This suggests the options market is pricing in considerably higher future price fluctuations than recent historical movements.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment